International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

Détails

ID Serval
serval:BIB_1580
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.
Périodique
Clinical Infectious Diseases
Auteur⸱e⸱s
Edwards J.E., Bodey G.P., Bowden R.A., Büchner T., de Pauw B.E., Filler S.G., Ghannoum M.A., Glauser M., Herbrecht R., Kauffman C.A., Kohno S., Martino P., Meunier F., Mori T., Pfaller M.A., Rex J.H., Rogers T.R., Rubin R.H., Solomkin J., Viscoli C., Walsh T.J., White M.
ISSN
1058-4838
Statut éditorial
Publié
Date de publication
1997
Volume
25
Numéro
1
Pages
43-59
Langue
anglais
Notes
Publication types: Consensus Development Conference ; Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review - Publication Status: ppublish
Résumé
Because of the rapidly increasing incidence of serious candidal infections, a consensus conference of 22 investigators from the United States, Europe, and Japan was held to discuss strategies for the prevention and treatment of deep-organ infections caused by Candida species. Commonly asked questions concerning the management of candidal infections were selected for discussion by the participating investigators. Possible answers to the questions were developed by the investigators, who then voted anonymously for their preferences. In certain instances, unanimity or a strong consensus was the result. In all cases, the full spectrum of responses was recorded and is presented in this report. The forms of candidal infection addressed included candidemia, candiduria, hepatosplenic candidiasis (chronic systemic candidiasis), candidal endophthalmitis, and candidal peritonitis. Prevention and treatment strategies were considered for patients who have undergone surgery, for neutropenic and nonneutropenic patients, and for patients who have undergone bone marrow and solid organ transplantation. The therapeutic roles of amphotericin B (standard and lipid formulations) and the azoles were considered.
Mots-clé
Animals, Antifungal Agents/therapeutic use, Candidiasis/drug therapy, Candidiasis/immunology, Humans
Pubmed
Web of science
Open Access
Oui
Création de la notice
19/11/2007 13:08
Dernière modification de la notice
20/08/2019 13:44
Données d'usage